Latest Morpholines Stories
SAN DIEGO, Aug.
-- Results from X-VeRT, the first prospective exploratory study of a Factor Xa inhibitor in patients with atrial fibrillation undergoing cardioversion, will be presented during an ESC Congress 2014
The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news.
Array planning for potential return of MEK inhibitor BOULDER, Colo., Aug. 12, 2014 /PRNewswire/ -- Array BioPharma Inc.
Court Documents Indicate a Number of Xarelto Bleeding Lawsuits Have Been Filed In U.S.
Kyprolis Helped Patients Live 8.7 Months Longer Without Their Disease Worsening THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Aug.
SAN DIEGO, July 29, 2014 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune
HILDEN, Germany and LONDON, July 28, 2014 /PRNewswire/ -- - Collaboration aims to create and commercialize companion diagnostic using genomic data
The Rottenstein Law Group, a national personal injury law firm, has launched a new website dedicated to providing the public information about the dangers of Xarelto and legal options if they
However, Access Barriers Result in Greater Prescribing of Conventional Anticoagulants, According to Findings from Decision Resources Group BURLINGTON, Mass., July 23, 2014 /PRNewswire/ -- Decision
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.